Sensus Healthcare Inc
NASDAQ:SRTS

Watchlist Manager
Sensus Healthcare Inc Logo
Sensus Healthcare Inc
NASDAQ:SRTS
Watchlist
Price: 3.81 USD -5.22%
Market Cap: 62.6m USD
Section:
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one SRTS stock under the Base Case scenario is 5.68 USD. Compared to the current market price of 3.81 USD, Sensus Healthcare Inc is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SRTS Relative Value
Base Case
5.68 USD
Undervaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
79
vs Industry
48
Median 3Y
2
Median 5Y
2.8
Industry
2.3
Forward
2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
37
Median 3Y
12.1
Median 5Y
7.1
Industry
22.3
Forward
-11.3
More Details
34.6
P/OCF
P/OCF
Price to OCF
34.6
vs History
20
vs Industry
Median 3Y
-4.3
Median 5Y
-4.3
Industry
14.2
More Details
30.5
P/FCFE
P/FCFE
Price to FCFE
30.5
vs History
25
vs Industry
Median 3Y
-4.1
Median 5Y
-4.1
Industry
21.3
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
76
vs Industry
52
Median 3Y
1.5
Median 5Y
2
Industry
2.2
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
80
vs Industry
59
Median 3Y
1.5
Median 5Y
2.2
Industry
2.5
Forward
1.3
More Details
2.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.4
vs History
71
vs Industry
65
Median 3Y
2.7
Median 5Y
3.6
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
43
Median 3Y
6.9
Median 5Y
6.9
Industry
11.9
Forward
-10.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
43
Median 3Y
7.2
Median 5Y
6.5
Industry
16.7
Forward
-10.3
More Details
21.8
EV/OCF
EV/OCF
Enterprise Value to OCF
21.8
vs History
23
vs Industry
Median 3Y
-2.4
Median 5Y
-2.4
Industry
14.5
More Details
19.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.2
vs History
28
vs Industry
Median 3Y
-2.3
Median 5Y
-2.3
Industry
18.3
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
74
vs Industry
43
Median 3Y
1.7
Median 5Y
2.9
Industry
1.8
More Details

Multiples Across Competitors

SRTS Competitors Multiples
Sensus Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Sensus Healthcare Inc
NASDAQ:SRTS
62.6m USD 1.9 -22 -8 -7.7
US
Abbott Laboratories
NYSE:ABT
221.3B USD 5.1 15.9 20.2 28.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
201.1B USD 20.9 73.4 56.1 68.4
US
Boston Scientific Corp
NYSE:BSX
143.5B USD 7.4 51.4 30 40.9
US
Stryker Corp
NYSE:SYK
140.5B USD 5.8 47.9 23.2 28.2
IE
Medtronic PLC
NYSE:MDT
130.1B USD 3.8 27.2 15.2 21.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
58.6B USD 14.1 56.8 40.9 45.3
US
Becton Dickinson and Co
NYSE:BDX
54.9B USD 2.5 32.7 13.2 24.1
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR 2 22 12.6 17.7
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD 8.3 35.7 25.5 27.9
US
Resmed Inc
NYSE:RMD
36.3B USD 6.9 25.3 18.1 20.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Sensus Healthcare Inc
NASDAQ:SRTS
Average EV/EBITDA: 25.5
Negative Multiple: -8
-10%
N/A
US
Abbott Laboratories
NYSE:ABT
20.2
13%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
56.1
25%
2.2
US
Boston Scientific Corp
NYSE:BSX
30
21%
1.4
US
Stryker Corp
NYSE:SYK
23.2
13%
1.8
IE
Medtronic PLC
NYSE:MDT
15.2
8%
1.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
40.9
13%
3.1
US
Becton Dickinson and Co
NYSE:BDX
13.2
13%
1
DE
Siemens Healthineers AG
XETRA:SHL
12.6
12%
1
US
Edwards Lifesciences Corp
NYSE:EW
25.5
12%
2.1
US
Resmed Inc
NYSE:RMD
18.1
11%
1.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Sensus Healthcare Inc
NASDAQ:SRTS
Average EV/EBIT: 32.3
Negative Multiple: -7.7
16%
N/A
US
Abbott Laboratories
NYSE:ABT
28.1
23%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
68.4
26%
2.6
US
Boston Scientific Corp
NYSE:BSX
40.9
32%
1.3
US
Stryker Corp
NYSE:SYK
28.2
16%
1.8
IE
Medtronic PLC
NYSE:MDT
21.9
17%
1.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.3
14%
3.2
US
Becton Dickinson and Co
NYSE:BDX
24.1
28%
0.9
DE
Siemens Healthineers AG
XETRA:SHL
17.7
20%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27.9
13%
2.1
US
Resmed Inc
NYSE:RMD
20.1
13%
1.5

See Also

Summary
SRTS intrinsic value, competitors valuation, and company profile.
DCF Valuation
SRTS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SRTS stock valuation using valuation multiples.
Wall Street Estimates
SRTS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SRTS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 298,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.